Interestingly, recent evidence from well-characterized cohorts of ALS showed that the ε2 allele of the APOE gene (together with the presence of C9orf72 repeat expansion) significantly increases the risk of FTD in participants with ALS (73–76). This evidence concerns the gene C9orf72 and frontotemporal dementia.